SDK will concentrate management information regarding the personal care business through this integration. Furthermore, the company will strengthen the business by increasing the speed of product development through closer cooperation among sales, production and R&D units.
Under the new medium-term consolidated business plan PEGASUS, SDK will expand its businesses in various functional materials, including personal care products, as one of its “new growth businesses.” The company aims to increase annual sales from the personal care products business to 4 billion by 2015.
Pharmaceuticals for external application: Pharmaceuticals absorbed into the system by means other than injection or oral administration. SDK provides base materials for such pharmaceuticals.